Top Markets
Coin of the day
IQ-AI Limited IQ-AI Limited

IQ-AI Limited

IQAI
Rank in Stocks #99999
IQ-AI Limited, through its subsidiaries, develops software applications for the... IQ-AI Limited, through its subsidiaries, develops software applications for the healthcare industry in Jersey and the United States. Its products include IB Clinic, a toolkit of post-processing software plug-ins for integrating into existing medical image visualization applications; IB Rad Tech, a workflow engine that processes customized workflows; IB Neuro, which analyzes MR data sets and generates parametric perfusion maps quantifying changes in contrast over time; and IB Delta Suite that performs a various fundamental radiology operations, including image co-registration, subtraction, class map generation, and export. The company also offers IB DCE, which analyzes conventional T1 weighted images and generates an array of relevant perfusion and permeability parameters; IB Diffusion that analyzes MR diffusion-weighted images and generates apparent diffusion coefficient, extrapolated b-value, IVIM, and other parameter maps; and IB StoneChecker, a medical software tool to aid clinical decision making by providing information about a patient's kidney stone. In addition, it provides consulting services. The company was formerly known as Flying Brands Limited and changed its name to IQ-AI Limited in October 2018. IQ-AI Limited is based in Saint Helier, Jersey.
Share Price
$0.01122579
Market Cap
$27.70K
Change (1 day)
0.43%
Change (1 year)
-10.64%
Country
JE
Trade IQ-AI Limited (IQAI)

Category

P/E ratio for IQ-AI Limited (IQAI)
P/E ratio as of March 2026 TTM: -3.50
According to IQ-AI Limited latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -3.50. At the end of 2023 the company had a P/E ratio of -13.84.
P/E ratio history for IQ-AI Limited from 2000 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
2026 (TTM) -3.50 -62.51%
2024 -9.33 -32.60%
2023 -13.84 116.92%
2022 -6.38 -68.50%
2021 -20.25 0.04%
2020 -20.25 166.93%
2019 -7.58 187.84%
2018 -2.64 -67.00%
2017 -7.98 152.55%
2016 -3.16 0.99%
2015 -3.13 1,133.01%
2014 -0.25 -66.94%
2013 -0.77 -106.66%
2012 11.53 -3,681.73%
2011 -0.32 -99.13%
2010 -37.05 -677.66%
2009 6.41 -940.03%
2008 -0.76 -106.83%
2007 11.17 -39.51%
2006 18.47 68.37%
2005 10.97 -13.46%
2004 12.68 45.93%
2003 8.69 -18.61%
2002 10.67 7.49%
2001 9.93 -125.48%
2000 -38.98 0.00%
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
19.23 -649.74%
US
32.34 -1,024.59%
US
59.21 -1,792.54%
AU
22.75 -750.34%
JP
34.88 -1,097.14%
US
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.